AXA Framlington Health Z GBP Acc (FUND:B6WZJX0) - Fund price - Overview

Fund Report

AXA Framlington Health Fund Z GBP Acc

Key Stats
Morningstar® CategorySector Equity Healthcare
Manager NameDani Saurymper
Inception Date16/04/2012
NAV 22/01/2019GBX 263.00
Day Change-0.27%
12 Month Yield0.24%
ISINGB00B6WZJX05
SEDOLB6WZJX0
Dividend FrequencySemi-Annually
Net Assets (mil) 31/12/2018464.01 GBP
Wrapper AvailabilityAll
Our Minimum Initial Investment1.00 Share
Pricing FrequencyDaily
Dealing Cut off Time11:00:00
Regular InvestmentYes
Actual Initial Charge0.00%
Exit Charge-
Custody ChargeYes
Ongoing Cost0.82%
AMC0.75%
Fund Rebate-

Morningstar Rating™

StarRatingValueLabel_3

Morningstar Sustainability Rating

Above Average

Above Average


Sustainability Rating as of 30/11/2018

Benchmarks

Fund Benchmark

MSCI World/Health Care GR USD

Morningstar® Benchmark

MSCI World/Health Care NR USD

Growth Of 10,000 (GBP) 31/12/2018

How has this security performed
201320142015201620172018
Fund35.4030.4312.277.905.091.84
Category31.9225.2311.407.359.962.70
Benchmark33.7325.4412.7711.169.438.89
  • Fund: AXA Framlington Health Fund Z GBP Acc
  • Category: Sector Equity Healthcare
  • Benchmark: MSCI World/Health Care NR USD
Trailing Returns % (GBP) 22/01/2019
FundCatBmark
YTD7.744.142.10
3 Years Annualised9.8011.2212.02
5 Years Annualised11.8711.4013.18
10 Years Annualised13.9612.7313.38

Morningstar SRRI

Lower Risk
Higher Risk
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Potentially Lower ReturnsPotentially Higher Returns
Source: Morningstar

Investment Objective

The aim of this Fund is to provide long-term capital growth. The Fund invests in shares of listed healthcare companies including producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies, which the Manager believes will provide above-average returns. The Fund invests in companies of any size which can be based anywhere in the world albeit the Fund tends to be biased towards the US, as this is where the majority of healthcare related companies are based. The Manager selects shares based upon analysis of a company’s financial status, quality of its management, expected profitability and prospects for growth.

Portfolio Profile31/12/2018

Morningstar Style Box®

Equity Style

Large, Mid, SmallSize
Value, Blend, Growth
Style
Top Holdings
NameSector%
IncreaseDecreaseNew since last portfolio
UnitedHealth Group Inc Healthcare6.33
Merck & Co Inc Healthcare5.90
GlaxoSmithKline PLC Healthcare4.82
Medtronic PLC Healthcare3.84
Anthem Inc Healthcare3.80
Asset Allocation %
LongShortNet
Stocks96.610.0096.61
Bonds0.000.000.00
Cash3.370.003.37
Other0.020.000.02
Top Stock Regions
Region%
United States78.35
Eurozone8.73
United Kingdom6.31
Japan4.13
Europe - ex Euro2.48
Top Stock Sectors
Stock Sector%
Healthcare97.08
Technology2.92
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.